naveenpawar22

Windlas Biotech ltd

naveenpawar22 Zaktualizowano   
NSE:WINDLAS   WINDLAS BIOTECH LTD
Windlas Biotech is a Pharma company which provides CDMO service with Market cap pf 881 Cr.
P/E 18.8 vs Industry P/E 32
Quarterly sale & operating profit is improving

Technically Chart has completed it cup handle pattern and given the breakout which is been retested. Look good to accumulate for ATH Target. one can expect 30 to 40% from this.
Zlecenie aktywne:
It is trading at 415. Retesting it neckline . once retest is completed it shall move for its first target of 490.

Stop loss should be 395 on closing basis.

Not a stock recommendation . It is for educational purpose.
Zlecenie aktywne:
It has come down to 403. strong accumulation is going on in this stock. As a investor one should be happy accumulate at lower levels.

It is for educational purpose. consult your financial advisor before investing.
Zlecenie aktywne:
It has jumped more than 11% taking the price to 476. Today it has made a ATH of 500.some profit booking might be there.

Now 450 -466 should act as a support.

Not a Buy/Sell Recommendation.
Zlecenie aktywne:
It is trading at 498. Made a all time high of 544.

466 should be kept as SL on closing basis.

Still long way to go

This is for Educational Purpose. Not a Buy/Sell Recommendation.
Zlecenie aktywne:
It is trading at 484 now.

440 to 460 is good price to accumulate it for higher target

This is for Educational Purpose. Not a Buy/Sell Recommendation.
Zlecenie aktywne:
It is trading at 468.

It is still in upward trend. If it breakdown it will be a oppurtunity to accumulate it.

Final Stop loss should be 405 on closing basis.

This is for Educational Purpose. Not a Buy/Sell Recommendation.
Zlecenie aktywne:
It is trading at 547. Following the uptrend channel.

It is unable to give closing above it resistance of 558.

Zlecenie aktywne:
Now it is at 580.

602 will be the target for cup and handle pattern breakout..smoothly it is in upward channel.

Still more to go
Wyłączenie odpowiedzialności

Informacje i publikacje przygotowane przez TradingView lub jego użytkowników, prezentowane na tej stronie, nie stanowią rekomendacji ani porad handlowych, inwestycyjnych i finansowych i nie powinny być w ten sposób traktowane ani wykorzystywane. Więcej informacji na ten temat znajdziesz w naszym Regulaminie.